Comparative Efficacy and Safety of Corticosteroids vs. No Corticosteroids in Septic Shock Intensive Care Unit Patients: A Systematic Review and Meta-Analysis
8 affiliations
- 1Department of Clinical Practice, Faculty of Pharmacy, Northern Border University, Rafha, Saudi Arabia
- 2Pediatric Emergency Medicine, Ministry of Health, Sohar Hospital, Sohar, Oman
- 3Department of Intensive Care Unit, Althaghr Hospital, Jeddah, Saudi Arabia
- 4Department of Pharmacy Practice and therapeutics, College of Pharmacy, University of Sharjah (UOS), Fujairah, United Arab Emirates
- 5Department of Emergency Medicine, College of Medicine, Prince Sattam Bin Abdulaziz University, Riyadh, Saudi Arabia
- 6College of Pharmacy, Qassim University, Al-Qassim, Saudi Arabia
- 7College of Pharmacy, Buraydah Colleges, Al-Qassim, Saudi Arabia
- 8College of Medicine, Qassim University, Al-Qassim, Saudi Arabia
Abstract
Background: Septic shock carries a high intensive care unit (ICU) mortality. The role of adjunctive corticosteroid therapy is controversial, with conflicting signals from trial-level meta-analyses, individual patient data syntheses, and large randomized trials. This review aimed to assess the comparative efficacy and safety of systemic corticosteroids versus no corticosteroids in adult ICU patients with septic shock.
Methods: Following the PRISMA 2020 guidelines, MEDLINE, Embase, CENTRAL, and Scopus were searched from inception, supplemented by trial registry and gray literature searches, for randomized trials of systemic corticosteroids versus placebo or standard care in adults with septic shock. Pooling used a random-effects model with restricted maximum likelihood estimation and Hartung–Knapp–Sidik–Jonkman adjustment. The Risk of Bias 2 and Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) frameworks were used for the methodological appraisal. Heterogeneity was quantified using I2, τ2, and 95% prediction intervals. Publication bias was assessed using contour-enhanced funnel plots, Egger’s regression test, and the Duval–Tweedie trim-and-fill method.
Results: Eleven randomized controlled trials (RCTs) (n = 6,332; 1,929 deaths) were included. Corticosteroids reduced 28-day all-cause mortality by 8.7% relative to control (pooled risk ratio (RR) 0.91, 95% confidence interval (CI) 0.86–0.97; P = 0.008; I2 = 0%; prediction interval 0.84–0.99), corresponding to 27 fewer deaths per 1,000 (10–44 fewer). Time to shock reversal was shortened by 1.25 days (95% CI −2.09 to −0.41), with the standardized mean difference (SMD) sensitivity analysis confirming a robust effect (SMD −0.41, 95% CI −0.51 to −0.32). Shock reversal incidence (RR 1.08, 0.99–1.19) and ICU length of stay (LOS) (mean difference (MD) −2.07 days, −6.50 to 2.36) favored corticosteroids without reaching significance. Hyperglycemia occurred more frequently in the corticosteroid arm of every contributing trial. Egger’s test (P = 0.972) and trim-and-fill imputation provided no evidence of small-study effects. GRADE certainty was moderate for mortality and shock reversal incidence, high for time to shock reversal, and low for ICU LOS and hyperglycemia.
Conclusion: Corticosteroid therapy in adults with septic shock was associated with a reduction in 28-day mortality and with accelerated shock reversal, with no evidence of publication bias. The direction of effect was consistent across pre-specified subgroups but was offset by a consistent excess of hyperglycemia, reinforcing the need for vigilant glucose surveillance during corticosteroid administration.
Related
- Efficacy of Platelet-Rich Plasma in the Treatment of Chronic Plantar Fasciitis Compared with Other Conventional Treatments (Corticosteroids and Shockwave Therapy): A Systematic Review
- Efficacy and Safety of Adjunctive Corticosteroids in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis of Randomized Trials
- Exercise self-efficacy plays a mediating role between social support and physical function among patients transferred from the intensive care unit
- Efficacy and safety of intralesional corticosteroids alone or in combination with other treatments for the management of keloids: a systematic review and meta-analysis
- Comparative efficacy of fruquintinib, regorafenib or TAS-102 in patients with KRAS-mutant metastatic colorectal cancer: a systematic review and network meta-analysis
BibTeX
@article{alqurain2026comparative,
title = {{Comparative Efficacy and Safety of Corticosteroids vs. No Corticosteroids in Septic Shock Intensive Care Unit Patients: A Systematic Review and Meta-Analysis}},
author = {Aymen Ali Alqurain and Ali Abdullah Shahmurad Albalushi and Amr Korani Soltan Abdeltawab and Khadeijah Ahmed Almarshoodi and Fahd Alrumaih and Wateen Mohammed Almutairi and Bayan Abdullah Alnasser and Omar Ibrahim Alsaleem and Abdullah Ibrahim Aldhobaib and Thamer Ibrahim Alshridha and Aryam Ahmad Alomaireeni and Nader Faleh Alenzi and Rawabi Mohammed Alwashmi and Abdullah Mohammed Muhunna Alwashmi and Khayal Abaalkhayl},
journal = {Journal of Clinical Medicine Research},
year = {2026},
month = oct,
doi = {10.14740/jocmr6631},
url = {https://europepmc.org/article/PMC/PMC13719637},
note = {CC BY},
}
RIS
TY - JOUR
TI - Comparative Efficacy and Safety of Corticosteroids vs. No Corticosteroids in Septic Shock Intensive Care Unit Patients: A Systematic Review and Meta-Analysis
AU - Aymen Ali Alqurain
AU - Ali Abdullah Shahmurad Albalushi
AU - Amr Korani Soltan Abdeltawab
AU - Khadeijah Ahmed Almarshoodi
AU - Fahd Alrumaih
AU - Wateen Mohammed Almutairi
AU - Bayan Abdullah Alnasser
AU - Omar Ibrahim Alsaleem
AU - Abdullah Ibrahim Aldhobaib
AU - Thamer Ibrahim Alshridha
AU - Aryam Ahmad Alomaireeni
AU - Nader Faleh Alenzi
AU - Rawabi Mohammed Alwashmi
AU - Abdullah Mohammed Muhunna Alwashmi
AU - Khayal Abaalkhayl
PY - 2026
DA - 2026/10/01
JO - Journal of Clinical Medicine Research
DO - 10.14740/jocmr6631
UR - https://europepmc.org/article/PMC/PMC13719637
AB - Background: Septic shock carries a high intensive care unit (ICU) mortality. The role of adjunctive corticosteroid therapy is controversial, with conflicting signals from trial-level meta-analyses, individual patient data syntheses, and large randomized trials. This review aimed to assess the comparative efficacy and safety of systemic corticosteroids versus no corticosteroids in adult ICU patients with septic shock. Methods: Following the PRISMA 2020 guidelines, MEDLINE, Embase, CENTRAL, and Scopus were searched from inception, supplemented by trial registry and gray literature searches, for randomized trials of systemic corticosteroids versus placebo or standard care in adults with septic shock. Pooling used a random-effects model with restricted maximum likelihood estimation and Hartung–Knapp–Sidik–Jonkman adjustment. The Risk of Bias 2 and Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) frameworks were used for the methodological appraisal. Heterogeneity was quantified using I2, τ2, and 95% prediction intervals. Publication bias was assessed using contour-enhanced funnel plots, Egger’s regression test, and the Duval–Tweedie trim-and-fill method. Results: Eleven randomized controlled trials (RCTs) (n = 6,332; 1,929 deaths) were included. Corticosteroids reduced 28-day all-cause mortality by 8.7% relative to control (pooled risk ratio (RR) 0.91, 95% confidence interval (CI) 0.86–0.97; P = 0.008; I2 = 0%; prediction interval 0.84–0.99), corresponding to 27 fewer deaths per 1,000 (10–44 fewer). Time to shock reversal was shortened by 1.25 days (95% CI −2.09 to −0.41), with the standardized mean difference (SMD) sensitivity analysis confirming a robust effect (SMD −0.41, 95% CI −0.51 to −0.32). Shock reversal incidence (RR 1.08, 0.99–1.19) and ICU length of stay (LOS) (mean difference (MD) −2.07 days, −6.50 to 2.36) favored corticosteroids without reaching significance. Hyperglycemia occurred more frequently in the corticosteroid arm of every contributing trial. Egger’s test (P = 0.972) and trim-and-fill imputation provided no evidence of small-study effects. GRADE certainty was moderate for mortality and shock reversal incidence, high for time to shock reversal, and low for ICU LOS and hyperglycemia. Conclusion: Corticosteroid therapy in adults with septic shock was associated with a reduction in 28-day mortality and with accelerated shock reversal, with no evidence of publication bias. The direction of effect was consistent across pre-specified subgroups but was offset by a consistent excess of hyperglycemia, reinforcing the need for vigilant glucose surveillance during corticosteroid administration.
SN - 1918-3003
SN - 1918-3011
ER -